It modulates cancer stem cell stemness and pluripotency by targeting many embryonic transcriptional factors that enhance the oncogenic activity of metastatic cancers, including OCT4, SOX2, NanoG, and KLF4 [95]. This evidence concerns the gene SOX2 and cancer.